HALO
Halozyme Therapeutics Inc.
$65.33
+$1.23(+1.92%)
53
Overall
60
Value
25
Tech
76
Quality
Market Cap
$7.50B
Volume
1.65M
52W Range
$42.01 - $79.50
Target Price
$76.00
EPS Estimates Overview
| Current Quarter | $1.54 | Next Quarter | $1.84 |
| Current Year | $5.85 | Next Year | $7.29 |
| QoQ Growth | +19.5% | YoY Growth | +24.6% |
| 3Y EPS CAGR | +7.0% | Target Price | $76.00 |
| Consensus | Buy | Upside | +16.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $65.33 | +1.9% | 1.65M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW